The Patent Finder

Terms ending in 2043

Cellectis

Every in-force patent on Cellectis's record whose computed term ends in 2043, whoever holds it now. Soonest term end first, then patent number.
PatentTitleHolderStatusExpiresConfidence
US 12,618,048Dual Car-T Cells
In force
 · High confidence
Cellectis S.A.In forceHigh confidence
US 12,534,744Methods to Genetically Modify Cells for Delivery of Therapeutic Proteins
In force
 · High confidence
Cellectis S.A.In forceHigh confidence
US 12,753,220New mesothelin specific chimeric antigen receptors (CAR) for solid tumors cancer immunotherapy
In force
 · High confidence
CellectisIn forceHigh confidence
3 of 3 patents shown. Soonest term end first, then patent number.
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited